+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

DelveInsight - Market Research Reports

Delve Insight authors market leading reports across the pharmaceutical and biotechnology sectors. The key findings and insights all come from regular monitoring of developments through the pharmaceutical and biotechnology sectors. These findings are then published through market forecasts, drug pipelines and drug insights, along with advice from top market analysts on how to best use this, alongside the detailed market forecasts offered by Delve Insight.

5-HT2 Agonist - Pipeline Insight, 2025 - Product Thumbnail Image

5-HT2 Agonist - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 80 Pages
  • Global
From
5-HT4 Agonist - Pipeline Insight, 2025 - Product Thumbnail Image

5-HT4 Agonist - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 120 Pages
  • Global
From
5-HT4 Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

5-HT4 Antagonist - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Vasopressin V2 Receptor (V2R) Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

Vasopressin V2 Receptor (V2R) Antagonist - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Muscarinic Acetylcholine Receptor M1 Antagonists- Pipeline Insight, 2025 - Product Thumbnail Image

Muscarinic Acetylcholine Receptor M1 Antagonists- Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Interleukin-33 Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Interleukin-33 Inhibitors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
From
Opioid Mu Receptor Antagonists - Pipeline Insight, 2025 - Product Thumbnail Image

Opioid Mu Receptor Antagonists - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
From
Adenosine Receptor Antagonists - Pipeline Insight, 2025 - Product Thumbnail Image

Adenosine Receptor Antagonists - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 80 Pages
  • Global
From
CDK12 Inhibitor- Pipeline Insight, 2025 - Product Thumbnail Image

CDK12 Inhibitor- Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Non-cystic Fibrosis Bronchiectasis - Pipeline Insight, 2025 - Product Thumbnail Image

Non-cystic Fibrosis Bronchiectasis - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
HPK1 Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

HPK1 Inhibitors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Complement Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Complement Inhibitors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 150 Pages
  • Global
From
Polycystic Kidney Disease - Pipeline Insight, 2025 - Product Thumbnail Image

Polycystic Kidney Disease - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
From
Polycystic Ovary Syndrome- Pipeline Insight, 2025 - Product Thumbnail Image

Polycystic Ovary Syndrome- Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Primary Mediastinal Large B-Cell Lymphoma - Pipeline Insight, 2025 - Product Thumbnail Image

Primary Mediastinal Large B-Cell Lymphoma - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 120 Pages
  • Global
From
Cholangiocarcinoma- Pipeline Insight, 2025 - Product Thumbnail Image

Cholangiocarcinoma- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 210 Pages
  • Global
From
Cholestatic Pruritus- Pipeline Insight, 2025 - Product Thumbnail Image

Cholestatic Pruritus- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Loading Indicator